Adaptive Biotechnologies Corp. (ADPT)
25.55
-0.44
(-1.69%)
USD |
NASDAQ |
Aug 24, 16:00
25.54
-0.01
(-0.04%)
After-Hours: 20:00
Adaptive Biotechnologies Shareholders Equity (Quarterly) : 142.91M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.91M |
| March 31, 2026 | 216.34M |
| December 31, 2025 | 218.79M |
| September 30, 2025 | 204.44M |
| June 30, 2025 | 179.72M |
| March 31, 2025 | 190.42M |
| December 31, 2024 | 202.71M |
| September 30, 2024 | 223.77M |
| June 30, 2024 | 241.60M |
| March 31, 2024 | 274.91M |
| December 31, 2023 | 308.40M |
| September 30, 2023 | 361.73M |
| June 30, 2023 | 396.04M |
| March 31, 2023 | 424.02M |
| December 31, 2022 | 464.16M |
| Date | Value |
|---|---|
| September 30, 2022 | 487.84M |
| June 30, 2022 | 518.30M |
| March 31, 2022 | 553.20M |
| December 31, 2021 | 603.99M |
| September 30, 2021 | 651.51M |
| June 30, 2021 | 693.18M |
| March 31, 2021 | 725.59M |
| December 31, 2020 | 743.27M |
| September 30, 2020 | 775.05M |
| June 30, 2020 | 529.94M |
| March 31, 2020 | 551.56M |
| December 31, 2019 | 571.04M |
| September 30, 2019 | 585.92M |
| June 30, 2019 | -284.37M |
| March 31, 2019 | -273.47M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Personalis, Inc. | 235.16M |
| 10X Genomics, Inc. | 825.55M |
| Alamar Biosciences, Inc. (California) | 312.86M |
| Champions Oncology, Inc. | 3.939M |
| Medpace Holdings, Inc. | 433.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 640.68M |
| Total Liabilities (Quarterly) | 490.02M |
| Debt to Equity Ratio | 2.872 |
| Current Ratio | 4.795 |
| Net Debt Paydown Yield | -1.11% |